COMMUNIQUÉ DE PRESSE
News
-
-
COMMUNIQUÉ DE PRESSE
Abivax Provides Update on Ulcerative Colitis Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease Mouse Model
Abivax announces preclinical data of Obefazimod and Etrasimod combination therapy in IBD mouse model, aiming to break through efficacy ceiling in UC treatment. More updates expected in Q4 2024 -
COMMUNIQUÉ DE PRESSE
Abivax fait le point sur la stratégie du programme de traitement combiné dans la RCH et annonce les données précliniques précoces de combinaison d’obefazimod et d’étrasimod dans un modèle murin MICI
Abivax annonce des données précliniques de combinaison d'obefazimod et d'étrasimod dans un modèle murin MICI pour traiter la RCH. Prochaine publication au T4 2024 -
COMMUNIQUÉ DE PRESSE
AngelAi's Commitment to Reducing Inequality - Advancing UN Sustainable Development Goal 10
AngelAi partners with Sun West to advance UN SDG 10 in promoting financial equality, reducing racial bias in banking and real estate sectors, empowering marginalized communities through inclusive innovation and cutting-edge AI-driven solutions -
-
-
COMMUNIQUÉ DE PRESSE
CPI Property Group – Sale of S IMMO AG shares to IMMOFINANZ AG
CPI Property Group announces sale of S IMMO AG shares to IMMOFINANZ AG, increasing stake to around 89%. Total purchase price of €608.5 million. Financing through €500 million credit facility from CPIPG. Related party transaction -
-
-
